Strong R&D infrastructure but slow to market - Senior Scientist Lupin Employee Review

2.0
19 May 2026
Recommend
CEO approval
Business outlook

Pros

Good infrastructure in R&D, manufacturing, robust compliance set up.

Cons

Compared to Pharma biologics seems weak. Long timelines from inception to market delivery. In comparison, other Indian biosimilar sponsors have gone far ahead.

Explore other reviews about Lupin

5.0
21 Nov 2025
Recommend
CEO approval
Business outlook

Pros

- good team - collaborative - amazing mentors

Cons

- office location, no public transport

3.0
3 May 2026
Recommend
CEO approval
Business outlook

Pros

Broad career exposure that you otherwise won't get in large companies.

Cons

Management directionless, indecisive, everyone just blaming everyone else,

See reviews by: Helpful|Rating|Date|All